Cargando…

Comparative effectiveness of multiple different treatment regimens for nonalcoholic fatty liver disease with type 2 diabetes mellitus: a systematic review and Bayesian network meta-analysis of randomised controlled trials

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are closely related and mutually contribute to the disease’s development. There are many treatment options available to patients. We provide a comprehensive overview of the evidence on the treatment effects of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Manjun, Wen, Yonghao, Yan, JingXin, Fan, Yichen, Wang, Zhixin, Zhang, Ruixia, Ren, Li, Ba, Yinggui, Wang, Haijiu, Lu, Qian, Fan, Haining
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655371/ https://www.ncbi.nlm.nih.gov/pubmed/37974258 http://dx.doi.org/10.1186/s12916-023-03129-6

Ejemplares similares

Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
por: Yan, Jingxin, et al.
Publicado: (2022)

Construction and validation of a prediction model of extrahepatic metastasis for hepatocellular carcinoma based on common clinically available data
por: Zhou, Liuxin, et al.
Publicado: (2022)

Suspected Regional Lymph Node Metastasis in Hepatic Alveolar Echinococcosis: A Case Report
por: WANG, Qiang, et al.
Publicado: (2020)

Kidney invasion occurred 2 years following liver transplantation for hepatic alveolar echinococcosis: a case report
por: Hu, Qirui, et al.
Publicado: (2023)

Acute symptomatic seizure due to tacrolimus-related encephalopathy after liver transplantation: two case reports
por: Li, Yao, et al.
Publicado: (2019)

Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews
por: Yan, Jingxin, et al.
Publicado: (2023)

The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease
por: Ren, Bin, et al.
Publicado: (2021)

Single-center experience of Ex vivo liver resection and autotransplantation for complex hepatic alveolar echinoccosis
por: Yuan, Jiaqi, et al.
Publicado: (2023)

Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease
por: Huang, Yuanshe, et al.
Publicado: (2022)

Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Qi, Yueying, et al.
Publicado: (2021)

Correlation between systemic immune inflammatory index and prognosis of patients with hepatic alveolar hydatid disease and establishment of a nomogram prediction model
por: Xiaobin, Chen, et al.
Publicado: (2023)

Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus
por: Fan, Yanbo, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Dharmalingam, Mala, et al.
Publicado: (2018)

Studies on the effects of hypothermia combined with hypoxia on rat skeletal muscle and lipid metabolism based on AMPK/PGC1α pathway
por: Ruixia, Zhang, et al.
Publicado: (2021)

Screening for microRNA-based diagnostic markers in hepatic alveolar echinococcosis
por: Ren, Bin, et al.
Publicado: (2019)

Pancreatic pseudocyst, pancreatitis, and incomplete pancreas divisum in a child treated with endotherapy: a case report
por: Yan, Jingxin, et al.
Publicado: (2021)

The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
por: Le, Michael H., et al.
Publicado: (2022)

Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology
por: Huang, Yuanshe, et al.
Publicado: (2022)

Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease
por: Huang, Ruixian, et al.
Publicado: (2019)

Diagnosis and treatment of a case of hepatic mixed echinococcosis infection combined with distant organ metastasis
por: Xu, Xiaolei, et al.
Publicado: (2019)

The role of complement in nonalcoholic fatty liver disease
por: Guo, Zhenya, et al.
Publicado: (2022)

Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data
por: Mavrogiannaki, A. N., et al.
Publicado: (2013)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao, Yuqing, et al.
Publicado: (2016)

Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis
por: Dai, Wenjie, et al.
Publicado: (2017)

Low vs standardized dose anticoagulation regimens for extracorporeal membrane oxygenation: A meta-analysis
por: Lv, Xiaochai, et al.
Publicado: (2021)

Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice
por: Sun, JuanJuan, et al.
Publicado: (2020)

Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease
por: Sun, Tiantian, et al.
Publicado: (2023)

Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Zhou, Qiumei, et al.
Publicado: (2021)

Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
por: Cho, Hyo Jung, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease Is a Stepping Stone in the Path toward Diabetes Mellitus
por: Heo, Nae-Yun
Publicado: (2019)

Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus
por: Portillo-Sanchez, Paola, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
por: Muzica, Cristina M., et al.
Publicado: (2020)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2022)

Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification
por: Jiang, Guoyan, et al.
Publicado: (2022)

Association between triglyceride–glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus
por: Li, Wei, et al.
Publicado: (2022)

Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
por: Lu, Wenxia, et al.
Publicado: (2016)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2023)

Roles of RNA m6A modification in nonalcoholic fatty liver disease
por: Tan, Jian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ciel1j7500afvb9dmgf9fpmmhs